ARTICLE | Clinical News
KTN3379: Phase I started
November 9, 2015 8:00 AM UTC
Kolltan began an open-label, U.S. Phase I trial to evaluate KTN3379 prior to surgical resection of tumor in about 29 HPV-negative and HPV-positive patients with SCCHN. ...
Kolltan began an open-label, U.S. Phase I trial to evaluate KTN3379 prior to surgical resection of tumor in about 29 HPV-negative and HPV-positive patients with SCCHN. ...